| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Arkowitz David is a Chief Financial Officer at Seres Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | IBIO Ibio, Inc. | Director | Buy | 18,382 | $2.72 | $49,999.04 | New | -52.5% | +5.9% | |
| Feb 16, 2024 | MCRB Seres Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,939 | $1.08 | $4,254.12 | -2.1% | -12.0% | -20.7% | |
| Oct 30, 2023 | MCRB Seres Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 4,066 | $1.35 | $5,489.10 | -2.3% | -13.8% | -46.8% |